Lens extraction should be considered for PACG

Article

Lens extraction for PACG results in good long-term control of IOP, and should be considered among the armamentarium of approaches to treat PACG.

Lens extraction for primary angle-closure glaucoma (PACG) results in good long-term control of intraocular pressure (IOP), and should be considered among the armamentarium of approaches to treat PACG - especially for patients who have hyperopia, or a thick and anteriorly vaulted lens, according to a report in Current Opinion in Ophthalmology.

The authors of the report note that anatomical opening of the angle, IOP reduction, and improved vision are all benefits cited by proponents of lens extraction in PACG.

The evidence base for ophthalmic surgeons to consider lens extraction in the management of PACG has grown stronger recently thanks to randomized controlled trials, case-control studies and cohort studies. Such studies have also added to the discussion of whether trabeculectomy or goniosynechialysis should be combined with lens extraction.

New insights have also been gained thanks to imaging modalities, such as anterior segment optical coherence tomography, that are providing information on the mechanical features of the lens in angle closure. For example, lens thickness and lens vault are now quantifiable.

“A trend is emerging regarding the improvement in IOP control, reduced complication rates and reduced need for IOP-lowering medications in patients who undergo lens extraction for PACG,” the authors state.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.